- Home
- ALEC vs AXR Comparison
ALEC vs AXR Comparison
Compare ALEC & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- AXR
- Stock Information
- Founded
- ALEC 2013
- AXR 1961
- Country
- ALEC United States
- AXR United States
- Employees
- ALEC N/A
- AXR N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- AXR Homebuilding
- Sector
- ALEC Health Care
- AXR Real Estate
- Exchange
- ALEC Nasdaq
- AXR Nasdaq
- Market Cap
- ALEC 124.0M
- AXR 127.3M
- IPO Year
- ALEC 2019
- AXR N/A
- Fundamental
- Price
- ALEC $1.27
- AXR $19.97
- Analyst Decision
- ALEC Hold
- AXR
- Analyst Count
- ALEC 9
- AXR 0
- Target Price
- ALEC $3.40
- AXR N/A
- AVG Volume (30 Days)
- ALEC 3.0M
- AXR 8.2K
- Earning Date
- ALEC 11-06-2025
- AXR 12-12-2025
- Dividend Yield
- ALEC N/A
- AXR N/A
- EPS Growth
- ALEC N/A
- AXR 40.98
- EPS
- ALEC N/A
- AXR 2.48
- Revenue
- ALEC $69,048,000.00
- AXR $48,454,000.00
- Revenue This Year
- ALEC N/A
- AXR $28.57
- Revenue Next Year
- ALEC $314.69
- AXR N/A
- P/E Ratio
- ALEC N/A
- AXR $8.24
- Revenue Growth
- ALEC 12.26
- AXR N/A
- 52 Week Low
- ALEC $0.87
- AXR $17.60
- 52 Week High
- ALEC $4.18
- AXR $39.68
- Technical
- Relative Strength Index (RSI)
- ALEC 33.72
- AXR 37.99
- Support Level
- ALEC $1.16
- AXR $19.65
- Resistance Level
- ALEC $1.60
- AXR $21.93
- Average True Range (ATR)
- ALEC 0.13
- AXR 1.04
- MACD
- ALEC 0.03
- AXR -0.12
- Stochastic Oscillator
- ALEC 22.73
- AXR 19.62
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.